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"CONTRIBUTION**What are the novel findings of this work?**This work provides a comparative analysis of the effect on perinatal outcome of several monitoring techniques for early‐onset fetal growth restriction employed in two randomized trials. The rate of survival without neurodevelopmental impairment at 2 years was highest in pregnancies monitored using computerized cardiotocography and ductus venosus Doppler.**What are the clinical implications of this work?**This analysis supports the hypothesis that the optimal method for fetal monitoring in pregnancies complicated by early‐onset fetal growth restriction is a combination of computerized cardiotocography and ductus venosus Doppler assessment."

INTRODUCTION {#uog20354-sec-0005}
============

Fetal growth restriction (FGR) in the early preterm period before 32 weeks\' gestation is a rare but serious complication of pregnancy owing to its association with adverse perinatal outcome. Treatment of the underlying condition is impossible and the challenge therefore lies in optimizing the timing of delivery. The risks associated with prematurity, namely neonatal complications and impaired neurodevelopment, have to be balanced against the risks associated with prolonged fetal exposure to hypoxemia and acidemia, which may result in stillbirth or brain damage. Obstetricians use a range of tests of fetal wellbeing. However, the sequence of events in fetal deterioration is difficult to evaluate in humans because observational case series of growth‐restricted fetuses rarely, if ever, include all tests of wellbeing. More importantly, study outcomes are inevitably 'censored' because timing of delivery is subject to the vagaries of parental choice and the decisions of managing clinicians[1](#uog20354-bib-0001){ref-type="ref"}. The optimal indication for timing of delivery is still open to debate[2](#uog20354-bib-0002){ref-type="ref"}.

Trials in this patient group are hard to conduct. To date, only two large randomized trials have evaluated timing of delivery in early‐onset preterm FGR: the Growth Restriction Intervention Study (GRIT) and the Trial of Umbilical and Fetal Flow in Europe (TRUFFLE)[3](#uog20354-bib-0003){ref-type="ref"}, [4](#uog20354-bib-0004){ref-type="ref"}. Both have been cited frequently, but their influence on clinical practice is difficult to measure. Although GRIT recruited 548 women (588 fetuses) and TRUFFLE recruited 503 women, and both trials achieved very high follow‐up rates to 2 years, the number of participants at any specific gestational age or with similar clinical risk factors was small. Given the high dependency of clinical decision‐making on gestational age, the available analyses are necessarily underpowered.

In the absence of data from further trials, an interim solution would be to meta‐analyze the existing data. Ideally, this should be an individual patient data meta‐analysis (IPD‐MA).

The aim of the current analysis was to explore the effect on perinatal outcome of different fetal monitoring strategies for early‐onset FGR employed in GRIT and TRUFFLE.

METHODS {#uog20354-sec-0006}
=======

This study initially set out to perform a meta‐analysis of trials investigating the impact of fetal monitoring methods for FGR on long‐term infant outcome. A scoping literature search was performed in PubMed, using the following strategy, limited to clinical trials: '(fetal compromise\[Title/Abstract\] or fetal monitoring\[Title/Abstract\]) AND (growth restriction\[Title/Abstract\] OR fetal growth\[Title/Abstract\]) AND (long term\[Title/Abstract\] OR long‐term\[Title/Abstract\] OR wellbeing\[Title/Abstract\] OR neurodevelopment\[Title/Abstract\] OR Griffith\[Title/Abstract\] OR Bayley\[Title/Abstract\])'. This confirmed that GRIT and TRUFFLE are the only monitoring/intervention studies in early‐onset FGR[3](#uog20354-bib-0003){ref-type="ref"}, [4](#uog20354-bib-0004){ref-type="ref"}. Differences in inclusion criteria, study period and study intervention between the two trials precluded an IPD‐MA, so a cohort analysis of individual participant data from the GRIT and TRUFFLE studies was performed. Individual participant data were retrieved from both trial datasets. The methods of both studies have been described previously in full and are summarized below. This study was exempt from review by the institutional ethics review boards.

GRIT {#uog20354-sec-0007}
====

In GRIT[3](#uog20354-bib-0003){ref-type="ref"}, [5](#uog20354-bib-0005){ref-type="ref"}, 548 pregnant women between 24 and 36 completed weeks\' gestation were recruited at 69 European hospitals between 1993 and 2001. All fetuses had suspected FGR and the inclusion criterion was clinical uncertainty about whether immediate delivery was indicated. Fetal arterial Doppler and cardiotocography (CTG) were recorded before inclusion, and interpretation of these findings was according to local standards. Ductus venosus (DV) Doppler was not used. The women were allocated randomly to immediate delivery (*n* = 296 babies) or delayed delivery until the obstetrician was no longer uncertain (*n* = 292 babies). Mode of delivery and monitoring strategy in the delayed‐delivery group were at the discretion of the attending obstetrician. The main outcome was death or neurodevelopmental impairment at or beyond 2 years of age. Impairment was a composite outcome comprising any of cerebral palsy, little or no vision, requirement for a hearing aid, or Griffith\'s Mental Development Scales General Quotient ≤ 70, assessed by a Griffith‐trained assessor. For those infants who were not assessed in person at 2 years of age, the former three diagnoses were accepted based on either parental report or the child\'s family practitioner or pediatrician. The overall rate of death or severe impairment at 2 years was 17.2% in those with known outcome and there was no statistically significant difference between the randomization groups. Neurodevelopmental impairment occurred in 6.5% of assessed children. For the purpose of the current analysis, the original study endpoint definition was used, i.e. survival without neurodevelopmental impairment at or beyond 2 years of age.

TRUFFLE {#uog20354-sec-0008}
=======

In TRUFFLE[4](#uog20354-bib-0004){ref-type="ref"}, [6](#uog20354-bib-0006){ref-type="ref"}, 503 pregnant women between 26 and 32 completed weeks\' gestation were recruited at 20 European hospitals between 2005 and 2010. All pregnancies had a fetus with FGR, defined based on elevated umbilical artery pulsatility index (PI) and ultrasound biometry. Women were randomized to one of three groups in which delivery was determined either by reduced short‐term variation (STV) in fetal heart rate using computerized CTG (cCTG), or by early (PI \> 95^th^ centile) or late (absent or negative A‐wave) abnormalities on Doppler ultrasound assessment of the DV waveforms. The criteria for determining delivery were specified in detail and included specific cut‐offs for STV in all groups, although the intensity of monitoring was not prescribed. All ultrasonographers met predetermined criteria for performing DV Doppler measurements. The main outcome was survival without neurodevelopmental impairment at 2 years of age. Impairment comprised any of cerebral palsy, severe vision or hearing impairment or cognitive composite score on the Bayley Scales of Infant and Toddler Development (3^rd^ edition) of \< 85, evaluated by an assessor trained and accredited specifically for the trial. For those infants who were not assessed in person at 2 years of age, the former three diagnoses were accepted based on either parental report or the child\'s family practitioner or pediatrician. The overall rate of death or severe impairment at 2 years was 18.1% of all infants with known outcome, with no statistical difference between the groups. The overall rate of neurodevelopmental impairment at 2 years in assessed children was 9.7%, and was lower in the groups monitored using DV Doppler than in the group monitored using cCTG.

Data strategy {#uog20354-sec-0009}
-------------

For this analysis, we used data from the subset of participants in the GRIT study with a singleton pregnancy and gestational age between 26 and 32 completed weeks at study entry. From TRUFFLE, all pregnancies were included, except one in which neonatal data were missing. Baseline variables, process variables and outcomes were compared between groups, with specific focus on their relationship with antenatal death and 2‐year outcome. We combined 2‐year outcome data, defining 'survival free of impairment' as survival without cerebral palsy, severe visual impairment or hearing loss requiring a hearing aid, and either Griffith Quotient \> 70 (GRIT) or Bayley‐III (or adjusted Bayley‐II) Cognitive Composite Score ≥ 85 (TRUFFLE). The primary outcome was calculated for all infants with known outcome, including those with perinatal or late death, but excluding infants lost to 2‐year follow‐up.

Analysis strategy {#uog20354-sec-0010}
-----------------

Data were analyzed according to intervention and monitoring strategy: immediate delivery when fetal condition was uncertain (GRIT) or delayed delivery with monitoring using conventional CTG (GRIT), cCTG with STV calculation (GRIT and TRUFFLE) or cCTG with STV calculation and DV Doppler (both DV Doppler groups from TRUFFLE were combined, as the results were not statistically significantly different). A secondary analysis was performed to investigate differences in infant outcome over time. The years of the studies were grouped as 1993--1997 and 1998--2001 for GRIT, and 2005--2007 and 2008--2010 for TRUFFLE, i.e. dividing each study into a first and second half.

Parameters analyzed included monitoring strategy, year of randomization, gestational age at randomization, umbilical artery absent or reversed end‐diastolic (ARED) flow and birth‐weight *Z*‐score. Birth‐weight *Z*‐scores were calculated using the *in‐utero* estimated fetal weight model developed by Hadlock *et al*.[7](#uog20354-bib-0007){ref-type="ref"}. As estimated fetal weight was not recorded at inclusion in GRIT, we included birth weight in the analysis.

Statistical analysis {#uog20354-sec-0011}
--------------------

Baseline characteristics, process variables and outcomes were compared using two‐tailed tests by ANOVA, the Mann--Whitney *U*‐test or Pearson\'s chi‐square test, as appropriate.

The associations of demographic, clinical and diagnostic parameters at study inclusion with the endpoints was first explored using univariable analysis. Those parameters that were significantly different on univariable analysis between infants with normal 2‐year outcome and those with death or neurodevelopmental impairment were entered into multivariable logistic regression analyses to adjust for the association between parameters and to calculate odds ratios (OR) for survival without neurodevelopmental impairment at 2 years[7](#uog20354-bib-0007){ref-type="ref"}, [8](#uog20354-bib-0008){ref-type="ref"}. Regression analysis both with and without gestational age or birth weight was planned in order to determine if the ORs of intervention and monitoring strategy or study period for the primary outcome were affected by these parameters owing to possible collider bias.

Intervention and monitoring strategy or study period was initially entered into the logistic regression analysis and other parameters were added in a stepwise manner, based on the probability of survival without impairment at 2 years. The probability cut‐offs for entry into and removal from the model were set at 0.05 and at 0.10, respectively. Statistical calculations were performed using SPSS version 25 (IBM Corp., Armonk, NY, USA).

RESULTS {#uog20354-sec-0012}
=======

We included 238 women from GRIT and 502 women from TRUFFLE. Gestational age at inclusion and at delivery and birth weight were similar between all subgroups (Table [1](#uog20354-tbl-0001){ref-type="table"}). Because of the randomization sequence, allocation to different groups was spread evenly across the study years. More pregnancies had ARED flow at study entry in GRIT than in TRUFFLE (70% *vs* 41%; *P* \< 0.01). However, if later measurements were included, rates of umbilical artery ARED flow were comparable between the groups (64% on average). The interval to delivery was shorter in the GRIT delayed‐delivery groups than in the TRUFFLE groups (median 3 days *vs* 8 days; *P* \< 0.01). Fetal‐death rate was comparable between GRIT and TRUFFLE, but neonatal or late death was more frequent in GRIT (18% *vs* 6%; *P* \< 0.01). Fetal‐death rate was similar in women monitored by conventional CTG without STV and in those monitored by cCTG in GRIT (4.8% *vs* 5.5%), but perinatal mortality was lower in the GRIT cCTG group (13% *vs* 23%), although the difference did not reach statistical significance. The rate of survival without neurodevelopmental impairment at 2 years was lowest in the immediate‐delivery group and in pregnancies monitored by CTG without STV, with a higher rate in the cCTG groups and the highest rate in the cCTG + DV Doppler group (Pearson chi‐square, *P* \< 0.01). Figure [1](#uog20354-fig-0001){ref-type="fig"} shows a trend of decreasing perinatal‐death rate across these groups at different gestational ages at inclusion, which was most apparent for those included at the lowest gestational age (26--27 weeks). A similar trend was observed when data were grouped by year of randomization (Pearson chi‐square, *P* \< 0.01) (Figure [2](#uog20354-fig-0002){ref-type="fig"}). Other parameters that were associated significantly with survival without neurodevelopmental impairment at 2 years were gestational age at randomization, umbilical artery ARED flow, birth weight and birth‐weight *Z*‐score.

###### 

Characteristics and outcome of pregnancies complicated by early‐onset fetal growth restriction in GRIT and TRUFFLE studies, overall and according to intervention and monitoring strategy

  Parameter                                                                                                                             GRIT                   TRUFFLE             Total (*n* = 740)                                                       
  --------------------------------------------------------------------------------------------------------------------------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------
  Nulliparous                                                                                                                         74 (61)                  33 (53)                  33 (60)                  100 (61)                 218 (65)                 458 (62)
  GA at inclusion (weeks)                                                                                                        29.5 (28.5--31.0)        29.5 (28.5--31.5)        29.5 (28.5--30.5)        29.2 (27.9--30.1)        29.2 (27.9--30.4)        29.5 (28.1--30.5)
  Interval to delivery (days)[\*](#uog20354-note-0004){ref-type="fn"}                                                                 0 (0--1)                 4 (2--8)                 2 (1--8)                7 (2--17)                8 (3--17)                5 (1--14)
  Umbilical artery ARED flow                                                                                                                                                                                                                               
  At inclusion[\*](#uog20354-note-0004){ref-type="fn"}                                                                                85 (70)                  44 (71)                  37 (67)                  61 (37)                  147 (44)                 374 (51)
  At any time                                                                                                                         85 (70)                  44 (71)                  37 (67)                  94 (57)                  210 (62)                 470 (64)
  Fetal death                                                                                                                          2 (2)                    3 (5)                    3 (5)                    2 (1)                    10 (3)                   20 (3)
  Live birth                                                                                                                          119 (98)                 59 (95)                  52 (95)                  163 (99)                 327 (97)                 720 (97)
  GA at delivery (weeks)                                                                                                         30.5 (28.6--31.5)        30.6 (29.0--32.4)        30.7 (29.6--31.6)        30.6 (29.0--32.0)        30.7 (29.3--32.3)        30.6 (29.1--31.9)
  Birth weight (g)                                                                                                                880 (740--1100)          920 (745--1085)          928 (733--1068)          965 (800--1115)          990 (806--1200)          953 (780--1160)
  Birth‐weight *Z*‐score                                                                                                       --3.3 (--3.9 to --2.4)   --3.3 (--4.3 to --2.7)   --3.5 (--4.1 to --2.8)   --3.3 (--3.8 to --2.7)   --3.3 (--3.8 to --2.8)   --3.3 (--3.8 to --2.8)
  Neonatal death[\*](#uog20354-note-0004){ref-type="fn"}                                                                              23 (19)                  11 (18)                   4 (7)                    10 (6)                   17 (5)                   65 (9)
  Late death[†](#uog20354-note-0005){ref-type="fn"}                                                                                    3 (2)                    0 (0)                    1 (2)                    1 (1)                   1 (0.3)                   6 (1)
  Evaluated at 2 years                                                                                                                91 (75)                  45 (73)                  46 (84)                  131 (79)                 271 (80)                 584 (79)
  Severe impairment[‡](#uog20354-note-0006){ref-type="fn"}, [§](#uog20354-note-0007){ref-type="fn"}                                   4/91 (4)                 2/45 (4)                 1/46 (2)                6/131 (5)                3/271 (1)                16/584 (3)
  Abnormal development[§](#uog20354-note-0007){ref-type="fn"}                                                                         8/91 (9)                 4/45 (9)                 3/46 (7)               20/131 (15)               19/271 (7)               54/584 (9)
  Alive with normal development at 2 years[\*](#uog20354-note-0004){ref-type="fn"}, [¶](#uog20354-note-0008){ref-type="fn"}     83/119 (70 (61--78))     41/59 (69 (57--82))      43/54 (80 (68--91))     111/144 (77 (70--84))    252/299 (84 (80--89))    530/675 (79 (75--82))

Data are given as *n* (%), median (interquartile range), *n*/*N* (%) or *n*/*N* (% (95% CI)).

Distribution differed between groups (Kruskal--Wallis test or Pearson chi‐square; *P* \< 0.05).

Defined as death after first discharge and before 2 years of age.

Severe hearing or vision impairment or cerebral palsy.

Percentage of infants evaluated at 2 years.

Percentage of all infants with known outcome.

ARED, absent/reversed end‐diastolic; CTG, cardiotocography; cCTG, computerized CTG; DV, ductus venosus; GA, gestational age; STV, short‐term variation in fetal heart rate.

![Rates of normal development (![](UOG-55-68-g004.jpg "image")), neurodevelopmental impairment (![](UOG-55-68-g005.jpg "image")) and perinatal death (![](UOG-55-68-g006.jpg "image")) by 2 years of age in children from pregnancies included in GRIT and TRUFFLE studies, randomized at 26--27 weeks (a), 28--29 weeks (b) and 30--31 weeks (c), according to intervention/monitoring method. Pearson chi‐square test between subgroups, *P* \< 0.05; *N* = 675; 65 women lost to follow‐ up were excluded. CTG, cardiotocography; cCTG, computerized CTG; DV, ductus venosus; STV, short‐term variation in fetal heart rate.](UOG-55-68-g001){#uog20354-fig-0001}

![Rates of normal development (![](UOG-55-68-g007.jpg "image")), neurodevelopmental impairment (![](UOG-55-68-g008.jpg "image")) and perinatal death (![](UOG-55-68-g009.jpg "image")) by 2 years of age in children from pregnancies included in GRIT and TRUFFLE studies, randomized at 26--27 weeks (a), 28--29 weeks (b) and 30--31 weeks (c), according to year of randomization. Pearson chi‐square test between subgroups, *P* \< 0.05; *N* = 675; 65 women lost to follow‐up were excluded.](UOG-55-68-g002){#uog20354-fig-0002}

Because the study periods of GRIT and TRUFFLE differed (1993--2001 *vs* 2005--2010) and study period and monitoring strategy were strongly associated (Pearson correlation coefficient, 0.82), it was not appropriate to combine these in one regression analysis. We therefore performed separate regression analyses for monitoring method and for year of inclusion, alongside the other parameters that were associated significantly with survival without impairment at 2 years, except birth weight and birth‐weight *Z*‐score, which were omitted because they were correlated with both gestational age and umbilical artery ARED flow. The addition of gestational age did not affect the ORs of monitoring strategy and study period for survival without impairment at 2 years, but the area under the receiver--operating characteristics curve (AUC) of the regression model increased from 0.63 to 0.69. The ORs for the model are shown in Figure [3](#uog20354-fig-0003){ref-type="fig"}. Gestational age at inclusion and umbilical artery ARED flow, which are both measures of the severity of FGR, had a strong association with survival without impairment at 2 years. Year of inclusion and monitoring strategy had similar, moderate effects.

![Odds ratios for survival without neurodevelopmental impairment at 2 years in children from pregnancies complicated by early‐onset fetal growth restriction included in GRIT and TRUFFLE studies, calculated using multivariable regression model including intervention/monitoring method (area under receiver--operating characteristics curve (AUC), 0.69 (95% CI, 0.64--0.74)) (a) or year of inclusion (AUC, 0.68 (95% CI, 0.63--0.73)) (b). ARED, absent/reversed end‐diastolic; CTG, cardiotocography; cCTG, computerized CTG; DV, ductus venosus; STV, short‐term variation in fetal heart rate.](UOG-55-68-g003){#uog20354-fig-0003}

DISCUSSION {#uog20354-sec-0013}
==========

This study found a trend for improved long‐term infant outcome using more advanced fetal monitoring strategies for early‐onset FGR, with lower rates of neonatal death and neurodevelopmental impairment at 2 years, after adjustment for severity of FGR based on gestational age at delivery and umbilical artery ARED flow.

We had initially intended to perform an IPD‐MA. However, conventional meta‐analysis was not possible owing to differences in inclusion criteria and type of interventions in GRIT and TRUFFLE. Although inclusion criteria differed, the study populations were very similar with regard to gestational age, birth weight and birth‐weight *Z*‐score. Umbilical artery ARED flow on Doppler examination at inclusion was more frequent in GRIT. GRIT participants were included if there was uncertainty regarding the necessity of delivering the fetus and were probably at a later stage of the pathological process of FGR at inclusion than were TRUFFLE participants. As a result, in TRUFFLE, the interval from inclusion to delivery was longer and, when later Doppler measurements were included, ARED flow became as frequent as in GRIT.

A problem encountered was that the trials were performed during successive time periods, and it was not possible to separate outcome improvement due to advances in obstetric and neonatal care from the effects of differences in monitoring strategy between the trials. On statistical analysis, both study period and intervention/monitoring method were highly correlated. Both seemed to have an effect on survival without neurodevelopmental impairment at 2 years, but the proportional contribution of these parameters could not be determined exactly.

Birth weight and gestational age have a potential for collider stratification bias, as they are not independent parameters in a population of pregnancies with early preterm FGR. They are influenced by severity of FGR, monitoring method and the decision to deliver the fetus at a certain moment. More data on the underlying pathology of FGR would have been useful to improve outcome prediction; unfortunately, except for Doppler variables, there are no appropriate markers for the underlying pathology of FGR. Therefore, gestational age in this study should be regarded as a proxy for the severity of FGR, and not as an independent variable. The study population was fairly uniform in its selection through functional Doppler markers of FGR, and we expect that this resulted in similar underlying pathologies of FGR in the intervention groups. A further argument supporting the notion that collider bias by gestational age is unlikely is that regression analysis with or without the inclusion of gestational age resulted in similar ORs for monitoring strategy and study period, while the AUC for the model increased with the addition of gestational age.

The two studies used two different tests to assess neurodevelopmental outcome; Griffiths General Quotients were used in GRIT and Bayley Cognitive Composite Scores were used in TRUFFLE, with different cut‐offs commensurate with prevailing practice. Using a cut‐off of \< 85 in TRUFFLE and a stricter cut‐off of ≤ 70 in GRIT, it would be unlikely that differences in developmental outcome were inflated in favor of TRUFFLE[9](#uog20354-bib-0009){ref-type="ref"}. This supports our conclusion that outcome was better in pregnancies that underwent monitoring with DV Doppler in TRUFFLE.

GRIT investigated immediate delivery in pregnancies with FGR when the clinician was uncertain as to whether to deliver the fetus. Fetal‐monitoring method and mode of delivery were at the discretion of the attending obstetrician. In contrast, TRUFFLE was designed to compare different monitoring strategies, and delivery criteria were specifically defined for each strategy. Cut‐offs for STV in TRUFFLE were defined according to the criteria of Dawes *et al*.[10](#uog20354-bib-0010){ref-type="ref"}, based on associations with fetal acidemia. DV Doppler cut‐offs were substantiated by longitudinal studies on monitoring parameters and adverse perinatal outcomes[1](#uog20354-bib-0001){ref-type="ref"}, [11](#uog20354-bib-0011){ref-type="ref"}. However, the minimum frequency of monitoring was not specified strictly (DV Doppler once per week, cCTG twice per week). Lack of a fixed, frequent schedule for monitoring in TRUFFLE and the complete absence of such data in GRIT preclude a secondary longitudinal analysis of monitoring techniques, which could have provided more information on their relative impact on decision‐making.

In both studies, delivery was indicated by criteria other than fetal distress. In GRIT, the indication for delivery was not included in the database, while in TRUFFLE, it is reported that 30% were delivered outside the prespecified monitoring criteria[12](#uog20354-bib-0012){ref-type="ref"}. Additionally, there were insufficient data regarding co‐interventions such as administration of corticosteroids, which were probably administered to nearly all patients, and magnesium sulfate, which was probably used in only a few patients for the prevention of eclampsia, as fetal neuroprotection was not used in clinical practice during the study periods. These restrictions hamper the combined analysis of data on the effect of monitoring strategy.

Our attempt to assess the superiority of cCTG over conventional CTG was only partly successful. Only a few studies have compared the predictive value of cCTG with that of CTG using visual inspection, while all previous studies assessed only short‐term outcomes and were underpowered for perinatal outcomes. Turan *et al*.[13](#uog20354-bib-0013){ref-type="ref"} described monitoring parameters in a cohort of 56 growth‐restricted fetuses and showed a slightly better correlation between low STV and low umbilical cord pH, as compared with traditional CTG. Another study showed no significant relationship between both methods and fetal or neonatal survival[14](#uog20354-bib-0014){ref-type="ref"}. To our knowledge, there are no published data comparing the efficacy of cCTG and standard CTG using visual inspection. Currently, probably owing to the limited association of cCTG with fetal hypoxemia and acidemia[15](#uog20354-bib-0015){ref-type="ref"}, [16](#uog20354-bib-0016){ref-type="ref"}, there is significant variation in the use of cCTG in clinical practice.

We observed an improvement in infant outcome over time and with increasing improvements in fetal monitoring techniques. This correlation is expected, as it is logical that advances in obstetric and neonatal care over the past 20 years will have had an effect on outcome, and that advances in fetal‐monitoring methods are a part of this.

In the group monitored using cCTG in GRIT, infant outcome was better than in the group monitored using CTG with visual assessment, although this difference was not statistically significant and might have been caused by differences between centers that used cCTG and those that did not. The main advantage of cCTG is that it provides a numerical result, which allows for a strict protocol‐based decision on intervention to be made, as applied in TRUFFLE. Its use is therefore essential for future intervention trials. However, it has not been proven to be superior in a head‐to‐head comparison.

In conclusion, this comparative analysis supports the hypothesis that the optimal method of fetal monitoring for early‐onset preterm FGR is a combination of cCTG and DV Doppler assessment.
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